The dvm360® pharmacy page is a comprehensive resource for clinical news and insights on the latest veterinary pharmacy. This page consists of articles, videos, interviews that include research on advancements and developments of therapies for veterinary care, and FDA approvals.
May 13th 2024
This initial conditional approval is valid for 1 year with the potential for 4 annual renewals
May 4th 2024
New indications approved by FDA for topical treatment of tick infestation in cats
September 8th 2022Both fluralaner topical solution (Bravecto) and fluralaner and moxidectin topical solution (Bravecto Plus) are now indicated for the treatment and control of Asian longhorned tick infestations in cats.